---
figid: PMC3760013__MOL2-7-776-g005
figlink: /pmc/articles/PMC3760013/figure/mol2201374776-fig-0005/
number: F5
caption: Core genes for cetuximab and PX‐866 susceptibility. Pathway enrichment analysis
  of cetuximab (above) and PX‐866 (below) from RNA‐seq according to susceptibility
  (sensitive vs. resistant). Red and green colors represent enrichment in sensitive
  and resistant group, respectively. Enrichment maps were abstracted from the pathways
  with P < 0.05 (GSEA analysis) by comparing RNA‐seq of sensitive vs. resistant models,
  and were manually adjusted to highlight the most relevant pathways for visualization
  purposes.
pmcid: PMC3760013
papertitle: A patient tumor transplant model of squamous cell cancer identifies PI3K
  inhibitors as candidate therapeutics in defined molecular bins.
reftext: Stephen B. Keysar, et al. Mol Oncol. 2013 Aug;7(4):776-790.
pmc_ranked_result_index: '138766'
pathway_score: 0.9538208
filename: MOL2-7-776-g005.jpg
figtitle: Core genes for cetuximab and PX‐866 susceptibility
year: '2013'
organisms:
- Homo sapiens
ndex: 04bdda4b-deb1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3760013__MOL2-7-776-g005.html
  '@type': Dataset
  description: Core genes for cetuximab and PX‐866 susceptibility. Pathway enrichment
    analysis of cetuximab (above) and PX‐866 (below) from RNA‐seq according to susceptibility
    (sensitive vs. resistant). Red and green colors represent enrichment in sensitive
    and resistant group, respectively. Enrichment maps were abstracted from the pathways
    with P < 0.05 (GSEA analysis) by comparing RNA‐seq of sensitive vs. resistant
    models, and were manually adjusted to highlight the most relevant pathways for
    visualization purposes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - RBPJ
  - MAPK3
  - MAPK1
  - MAP2K1
  - MAPK14
  - NRAS
  - KRAS
  - MAP2K2
  - MTOR
  - EIF4EBP1
  - AKT3
  - MAPK13
  - MAPK12
  - NOTCH4
  - HRAS
  - NOTCH3
  - RAF1
  - ARAF
  - BRAF
  - EGFR
  - MYC
  - NOTCH2
  - AKT1
  - MAPK10
  - NOTCH1
  - AKT2
  - CCND1
  - MAPK9
  - MAPK11
  - MAPK8
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: RBPJ
  symbol: RBPJ
  source: hgnc_symbol
  hgnc_symbol: RBPJ
  entrez: '3516'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: 4EBP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CCND1
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: NOTCH
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3760013__F5
redirect_from: /figures/PMC3760013__F5
figtype: Figure
---
